Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Graceway Pharmaceuticals (European Rights of Zyclara)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A medicinal formula for imiquimod topical cream. The company engages in the formulation and manufacture of medicinal cream used for the treatment of actinic keratosis.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Personal Products
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 340 Martin Luther King Junior Boulevard
  • Suite 500
  • Bristol, TN 37620
  • United States

Graceway Pharmaceuticals (European Rights of Zyclara) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Graceway Pharmaceuticals (European Rights of Zyclara)‘s full profile, request access.

Request full access to PitchBook

Graceway Pharmaceuticals (European Rights of Zyclara) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Graceway Pharmaceuticals (European Rights of Zyclara)‘s full profile, request access.

Request full access to PitchBook